58
Participants
Start Date
May 31, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
November 30, 2011
Cenderitide
Cenderitide is a novel rationally designed chimeric natriuretic peptide to be administered in this trial as either a subcutaneous injection or infusion.
Placebo
Placebo will be administered as a 24-hour SQ infusion
Jacksonville Center for Clinical Research, Jacksonville
Hennepin County Medical Center, Minneapolis
Analab Clinical Research, Inc., Lenexa
Benchmark Research, Metairie
Orange County Research Center, Tustin
Lead Sponsor
Collaborators (1)
Integrium
INDUSTRY
Nile Therapeutics
INDUSTRY